Get started
Charlestrad3r

Data due soon and ready to breakout

Long
Charlestrad3r  
NASDAQ:FPRX   None
Chart Patterns Technical Indicators Trend Analysis biotech breakouttrading
8
0
chartpattern indicator trendanalysis biotech breakouttrading
Catalysts
FPA144 + chemo Phase 3 futility analysis due 1H 2020
FPA150 Phase 1b Ovarian cancer data due 1H 2020
Cabiralizumab (FPA008) and Opdivo (nivolumab) Phase 2 Data due 2H 2020

- High hedge fund buying in December -
BVF Partners holds a 10% ownership, Frpx Ranks 22 in their portfolio
RENAISSANCE TECHNOLOGIES holds a 3.6% stake in the company

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.